Cargando…
Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses
Metastatic uveal melanoma (UM) patients typically survive only 2 to 3 years because effective therapy does not yet exist. Here, to facilitate the discovery of therapeutic targets in UM, we have identified protein kinase signaling mechanisms elicited by the drivers in 90% of UM tumors: mutant constit...
Autores principales: | Onken, Michael D., Erdmann-Gilmore, Petra, Zhang, Qiang, Thapa, Kisan, King, Emily, Kaltenbronn, Kevin M., Noda, Sarah E., Makepeace, Carol M., Goldfarb, Dennis, Babur, Özgün, Townsend, R. Reid, Blumer, Kendall J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616553/ https://www.ncbi.nlm.nih.gov/pubmed/37730182 http://dx.doi.org/10.1016/j.mcpro.2023.100649 |
Ejemplares similares
-
Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma
por: Onken, Michael D., et al.
Publicado: (2021) -
Targeting primary and metastatic uveal melanoma with a G protein inhibitor
por: Onken, Michael D., et al.
Publicado: (2021) -
Uveal melanoma cells use ameboid and mesenchymal mechanisms of cell motility crossing the endothelium
por: Onken, Michael D., et al.
Publicado: (2021) -
Functional characterization of uveal melanoma oncogenes
por: Ma, Jiafang, et al.
Publicado: (2020) -
Gq-Coupled Receptors in Autoimmunity
por: Zhang, Lu, et al.
Publicado: (2016)